TY - JOUR AU - Zhang, X. H. AU - Lu, Z. L. AU - Liu, L. PY - 2008 DA - 2008// TI - Coronary heart disease in China JO - Heart VL - 94 UR - https://doi.org/10.1136/hrt.2007.132423 DO - 10.1136/hrt.2007.132423 ID - Zhang2008 ER - TY - JOUR AU - Zhang, Y. AU - Wu, N. Q. AU - Li, S. AU - Zhu, C. G. AU - Guo, Y. L. AU - Qing, P. AU - Gao, Y. AU - Li, X. L. AU - Liu, G. AU - Dong, Q. AU - Li, J. J. PY - 2016 DA - 2016// TI - Non-HDL-C is a better predictor for the severity of coronary atherosclerosis compared with LDL-C JO - Heart Lung and Circulation VL - 25 UR - https://doi.org/10.1016/j.hlc.2016.04.025 DO - 10.1016/j.hlc.2016.04.025 ID - Zhang2016 ER - TY - JOUR AU - Zhou, M. G. AU - Wang, H. D. AU - Zhu, J. AU - Chen, W. Q. AU - Wang, L. H. AU - Liu, S. W. AU - Li, Y. C. AU - Wang, L. J. AU - Liu, Y. N. AU - Yin, P. PY - 2016 DA - 2016// TI - Cause-specific mortality for 240 causes in China during 1990-2013: a systematic subnational analysis for the global burden of disease study 2013 JO - Lancet VL - 387 UR - https://doi.org/10.1016/S0140-6736(15)00551-6 DO - 10.1016/S0140-6736(15)00551-6 ID - Zhou2016 ER - TY - JOUR AU - Hovingh, G. K. AU - Davidson, M. H. AU - Kastelein, J. J. P. AU - O'Connor, A. M. PY - 2013 DA - 2013// TI - Diagnosis and treatment of familial hypercholesterolaemia JO - Eur Heart J VL - 34 UR - https://doi.org/10.1093/eurheartj/eht015 DO - 10.1093/eurheartj/eht015 ID - Hovingh2013 ER - TY - JOUR AU - Raal, F. J. AU - Hovingh, G. K. AU - Catapano, A. L. PY - 2018 DA - 2018// TI - Familial hypercholesterolemia treatments: guidelines and new therapies JO - Atherosclerosis VL - 277 UR - https://doi.org/10.1016/j.atherosclerosis.2018.06.859 DO - 10.1016/j.atherosclerosis.2018.06.859 ID - Raal2018 ER - TY - JOUR AU - Stein, E. A. PY - 2002 DA - 2002// TI - Management of dyslipidemia in the high-risk patient JO - Am Heart J VL - 144 UR - https://doi.org/10.1067/mhj.2002.130302 DO - 10.1067/mhj.2002.130302 ID - Stein2002 ER - TY - JOUR AU - Feldman, H. A. AU - Zuber, K. AU - Davis, J. PY - 2017 DA - 2017// TI - Dyslipidemia how low should we go? A review of current lipid guidelines JO - Physician Assistant Clinics VL - 2 UR - https://doi.org/10.1016/j.cpha.2017.06.004 DO - 10.1016/j.cpha.2017.06.004 ID - Feldman2017 ER - TY - JOUR AU - Stroes, E. PY - 2005 DA - 2005// TI - Statins and LDL-cholesterol lowering: an overview JO - Curr Med Res Opin VL - 21 UR - https://doi.org/10.1185/030079905X59102 DO - 10.1185/030079905X59102 ID - Stroes2005 ER - TY - JOUR AU - Dembowski, E. AU - Davidson, M. H. PY - 2009 DA - 2009// TI - A review of lipid management in primary and secondary prevention JO - J Cardiopulm Rehabil Prev VL - 29 UR - https://doi.org/10.1097/HCR.0b013e318192754e DO - 10.1097/HCR.0b013e318192754e ID - Dembowski2009 ER - TY - JOUR AU - Shimizu, R. AU - Torii, H. AU - Yasuda, D. AU - Hiraoka, Y. AU - Kitada, N. AU - Hashida, T. AU - Yoshimoto, A. AU - Kita, T. AU - Kume, N. PY - 2015 DA - 2015// TI - Serum lipid goal attainment in chronic kidney disease (CKD) patients under the Japan atherosclerosis society (JAS) 2012 guidelines JO - J Atheroscler Thromb VL - 22 UR - https://doi.org/10.5551/jat.29165 DO - 10.5551/jat.29165 ID - Shimizu2015 ER - TY - JOUR AU - Shirai, K. PY - 2004 DA - 2004// TI - Obesity as the core of the metabolic syndrome and the management of coronary heart disease JO - Curr Med Res Opin VL - 20 UR - https://doi.org/10.1185/030079903125003008 DO - 10.1185/030079903125003008 ID - Shirai2004 ER - TY - JOUR AU - Stone, N. J. AU - Robinson, J. G. AU - Lichtenstein, A. H. AU - Merz, C. N. B. AU - Blum, C. B. AU - Eckel, R. H. AU - Goldberg, A. C. AU - Gordon, D. AU - Levy, D. AU - Lloyd-Jones, D. M. PY - 2014 DA - 2014// TI - 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines JO - Journal of the American College of Cardiology VL - 63 UR - https://doi.org/10.1016/j.jacc.2013.11.002 DO - 10.1016/j.jacc.2013.11.002 ID - Stone2014 ER - TY - JOUR AU - Anderson, T. J. AU - Gregoire, J. AU - Pearson, G. J. AU - Barry, A. R. AU - Couture, P. AU - Dawes, M. AU - Francis, G. A. AU - Genest, J. AU - Grover, S. AU - Gupta, M. PY - 2016 DA - 2016// TI - 2016 Canadian cardiovascular society guidelines for the Management of Dyslipidemia for the prevention of cardiovascular disease in the adult JO - Can J Cardiol VL - 32 UR - https://doi.org/10.1016/j.cjca.2016.07.510 DO - 10.1016/j.cjca.2016.07.510 ID - Anderson2016 ER - TY - STD TI - Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, Hoes AW, Jennings CS, Landmesser U, Pedersen TR, et al: 2016 ESC/EAS guidelines for the Management of Dyslipidaemias the Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European atherosclerosis society (EAS) developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR). Atherosclerosis 2016, 253:281–344. ID - ref14 ER - TY - JOUR AU - Adhyaru, B. B. AU - Jacobson, T. A. PY - 2016 DA - 2016// TI - New cholesterol guidelines for the Management of Atherosclerotic Cardiovascular Disease Risk a Comparison of the 2013 American College of Cardiology/American Heart Association cholesterol guidelines with the 2014 National Lipid Association Recommendations for patient-centered Management of Dyslipidemia JO - Endocrinol Metab Clin N Am VL - 45 UR - https://doi.org/10.1016/j.ecl.2015.09.002 DO - 10.1016/j.ecl.2015.09.002 ID - Adhyaru2016 ER - TY - JOUR AU - Cziraky, M. J. AU - Watson, K. E. AU - Talbert, R. L. PY - 2009 DA - 2009// TI - Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed Care setting JO - J Manag Care Pharm VL - 14 ID - Cziraky2009 ER - TY - JOUR AU - Contois, J. H. AU - Warnick, G. R. AU - Sniderman, A. D. PY - 2011 DA - 2011// TI - Reliability of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B measurement JO - J Clin Lipidol VL - 5 UR - https://doi.org/10.1016/j.jacl.2011.05.004 DO - 10.1016/j.jacl.2011.05.004 ID - Contois2011 ER - TY - JOUR AU - Ramjee, V. AU - Sperling, L. S. AU - Jacobson, T. A. PY - 2011 DA - 2011// TI - Non-high-density lipoprotein cholesterol versus apolipoprotein B in cardiovascular risk stratification do the math JO - J Am Coll Cardiol VL - 58 UR - https://doi.org/10.1016/j.jacc.2011.05.009 DO - 10.1016/j.jacc.2011.05.009 ID - Ramjee2011 ER - TY - JOUR AU - Enkhmaa, B. AU - Prakash, N. AU - Berglund, L. PY - 2018 DA - 2018// TI - Non-HDL-C levels and residual cardiovascular risk: do population-specific precision approaches offer any advantages? JO - Atherosclerosis VL - 274 UR - https://doi.org/10.1016/j.atherosclerosis.2018.05.010 DO - 10.1016/j.atherosclerosis.2018.05.010 ID - Enkhmaa2018 ER - TY - JOUR AU - Grundy, S. M. AU - Arai, H. AU - Barter, P. AU - Bersot, T. P. AU - Betteridge, J. AU - Carmena, R. AU - Cuevas, A. AU - Davidson, M. H. AU - Genest, J. AU - Kesaniemi, Y. A. PY - 2013 DA - 2013// TI - An international atherosclerosis society position paper: global recommendations for the management of dyslipidemia JO - Journal of Clinical Lipidology VL - 7 UR - https://doi.org/10.1016/j.jacl.2013.10.001 DO - 10.1016/j.jacl.2013.10.001 ID - Grundy2013 ER - TY - JOUR AU - Rabar, S. AU - Harker, M. AU - O'Flynn, N. AU - Wierzbicki, A. S. PY - 2014 DA - 2014// TI - Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance JO - BMJ VL - 349 UR - https://doi.org/10.1136/bmj.g4356 DO - 10.1136/bmj.g4356 ID - Rabar2014 ER - TY - JOUR AU - Pedersen, T. R. AU - Tobert, J. A. PY - 2004 DA - 2004// TI - Simvastatin: a review JO - Expert Opin Pharmacother VL - 5 UR - https://doi.org/10.1517/14656566.5.12.2583 DO - 10.1517/14656566.5.12.2583 ID - Pedersen2004 ER - TY - JOUR AU - Lindgren, P. AU - Jonsson, B. PY - 2009 DA - 2009// TI - From 4S to IDEAL: the health economics of the statin trials JO - Eur J Cardiovasc Prev Rehabil VL - 16 UR - https://doi.org/10.1097/HJR.0b013e328325d7dc DO - 10.1097/HJR.0b013e328325d7dc ID - Lindgren2009 ER - TY - JOUR AU - Simes, R. J. AU - Marschner, I. C. AU - Hunt, D. AU - Colquhoun, D. AU - Sullivan, D. AU - Stewart, R. A. H. AU - Hague, W. AU - Keech, A. AU - Thompson, P. AU - White, H. PY - 2002 DA - 2002// TI - Relationship between lipid levels and clinical outcomes in the long-term intervention with pravastatin in ischemic disease (LIPID) trial - to what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels? JO - Circulation VL - 105 UR - https://doi.org/10.1161/hc1002.105136 DO - 10.1161/hc1002.105136 ID - Simes2002 ER - TY - STD TI - Cui JS, Forbes A, Kirby A, Marschner I, Simes J, Hunt D, West M, Tonkin A. Semi-parametric risk prediction models for recurrent cardiovascular events in the LIPID study. BMC Med Res Methodol. 2010;10. ID - ref25 ER - TY - JOUR AU - Novack, V. AU - MacFadyen, J. AU - Malhotra, A. AU - Almog, Y. AU - Glynn, R. J. AU - Ridker, P. M. PY - 2012 DA - 2012// TI - The effect of rosuvastatin on incident pneumonia: results from the JUPITER trial JO - Can Med Assoc J VL - 184 UR - https://doi.org/10.1503/cmaj.111017 DO - 10.1503/cmaj.111017 ID - Novack2012 ER - TY - STD TI - Dugani S, Akinkuolie A, Glynn RJ, Ridker PM, Mora S. Lipoprotein subclasses, size, and statin-associated incident diabetes: an analysis from the JUPITER trial. Circulation. 2014:130. ID - ref27 ER - TY - JOUR AU - Keech, A. AU - Colquhoun, D. AU - Best, J. AU - Kirby, A. AU - Simes, R. J. AU - Hunt, D. AU - Hague, W. AU - Beller, E. AU - Arulchelvam, M. AU - Baker, J. PY - 2003 DA - 2003// TI - Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose - results from the LIPID trial JO - Diabetes Care VL - 26 UR - https://doi.org/10.2337/diacare.26.10.2713 DO - 10.2337/diacare.26.10.2713 ID - Keech2003 ER - TY - JOUR AU - Ip, C. K. AU - Jin, D. M. AU - Gao, J. J. AU - Meng, Z. AU - Meng, J. AU - Tan, Z. AU - Wang, J. F. AU - Geng, D. F. PY - 2015 DA - 2015// TI - Effects of add-on lipid-modifying therapy on top of background statin treatment on major cardiovascular events: a meta-analysis of randomized controlled trials JO - Int J Cardiol VL - 191 UR - https://doi.org/10.1016/j.ijcard.2015.04.228 DO - 10.1016/j.ijcard.2015.04.228 ID - Ip2015 ER - TY - JOUR AU - Ho, L. T. AU - Lin, F. J. AU - Tseng, W. K. AU - Yin, W. H. AU - Wu, Y. W. AU - Li, Y. H. AU - Yeh, H. I. AU - Chen, J. W. AU - Wu, C. C. AU - Pat, T. S. P. PY - 2018 DA - 2018// TI - On-treatment lipid profiles to predict the cardiovascular outcomes in ASCVD patients comorbid with chronic kidney disease - the multi-center T-SPARCLE registry study JO - J Formos Med Assoc VL - 117 UR - https://doi.org/10.1016/j.jfma.2018.05.020 DO - 10.1016/j.jfma.2018.05.020 ID - Ho2018 ER - TY - JOUR AU - Folse, H. J. AU - Goswami, D. AU - Rengarajan, B. AU - Budoff, M. AU - Kahn, R. PY - 2014 DA - 2014// TI - Clinical- and cost-effectiveness of LDL particle-guided statin therapy: a simulation study JO - Atherosclerosis VL - 236 UR - https://doi.org/10.1016/j.atherosclerosis.2014.06.027 DO - 10.1016/j.atherosclerosis.2014.06.027 ID - Folse2014 ER - TY - STD TI - Lawler PR, Akinkuolie AO, Chu AY, Shah SH, Kraus WE, Craig D, Padmanabhan L, Glynn RJ, Ridker PM, Chasman DI, Mora S. Atherogenic lipoprotein determinants of cardiovascular disease and residual risk among individuals with low low-density lipoprotein cholesterol. J Am Heart Assoc. 2017;6. ID - ref32 ER - TY - JOUR AU - Pradhan, A. D. AU - Aday, A. W. AU - Rose, L. M. AU - Ridker, P. M. PY - 2018 DA - 2018// TI - Residual inflammatory risk on treatment with PCSK9 inhibition and statin therapy JO - Circulation VL - 138 UR - https://doi.org/10.1161/CIRCULATIONAHA.118.034645 DO - 10.1161/CIRCULATIONAHA.118.034645 ID - Pradhan2018 ER - TY - JOUR AU - Soran, H. AU - Dent, R. AU - Durrington, P. PY - 2017 DA - 2017// TI - Evidence-based goals in LDL-C reduction JO - Clin Res Cardiol VL - 106 UR - https://doi.org/10.1007/s00392-016-1069-7 DO - 10.1007/s00392-016-1069-7 ID - Soran2017 ER - TY - STD TI - Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383–9. ID - ref35 ER - TY - JOUR AU - Pedersen, T. R. AU - Kjekshus, J. AU - Berg, K. AU - Haghfelt, T. AU - Faergeman, O. AU - Faergeman, G. AU - Pyorala, K. AU - Miettinen, T. AU - Wilhelmsen, L. AU - Olsson, A. G. PY - 1994 DA - 1994// TI - Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian simvastatin survival study (4S) JO - Atheroscler Suppl VL - 5 UR - https://doi.org/10.1016/j.atherosclerosissup.2004.08.027 DO - 10.1016/j.atherosclerosissup.2004.08.027 ID - Pedersen1994 ER - TY - JOUR AU - Iakoubova, O. A. AU - Tong, C. H. AU - Rowland, C. M. AU - Kirchgessner, T. G. AU - Young, B. A. AU - Arellano, A. R. AU - Shiffman, D. AU - Sabatine, M. S. AU - Campos, H. AU - Packard, C. J. PY - 2008 DA - 2008// TI - Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary heart disease in 2 prospective trials: the CARE and WOSCOPS trials JO - J Am Coll Cardiol VL - 51 UR - https://doi.org/10.1016/j.jacc.2007.05.057 DO - 10.1016/j.jacc.2007.05.057 ID - Iakoubova2008 ER - TY - JOUR AU - Lee, S. AU - Cannon, C. P. PY - 2018 DA - 2018// TI - Combination lipid-lowering therapies for the prevention of recurrent cardiovascular events JO - Curr Cardiol Rep VL - 20 UR - https://doi.org/10.1007/s11886-018-0997-4 DO - 10.1007/s11886-018-0997-4 ID - Lee2018 ER - TY - JOUR AU - Ballantyne, C. M. PY - 2003 DA - 2003// TI - Current and future aims of lipid-lowering therapy: changing paradigms and lessons from the heart protection study on standards of efficacy and safety JO - Am J Cardiol VL - 92 UR - https://doi.org/10.1016/S0002-9149(03)00768-9 DO - 10.1016/S0002-9149(03)00768-9 ID - Ballantyne2003 ER - TY - JOUR AU - Farmer, J. A. AU - Gotto, A. M. PY - 2003 DA - 2003// TI - The heart protection study: expanding the boundaries for high-risk coronary disease prevention JO - Am J Cardiol VL - 92 UR - https://doi.org/10.1016/S0002-9149(03)00503-4 DO - 10.1016/S0002-9149(03)00503-4 ID - Farmer2003 ER - TY - JOUR AU - Parish, S. AU - Offer, A. AU - Clarke, R. AU - Hopewell, J. C. AU - Hill, M. R. AU - Otvos, J. D. AU - Armitage, J. AU - Collins, R. PY - 2012 DA - 2012// TI - Heart protection study collaborative G: lipids and lipoproteins and risk of different vascular events in the MRC/BHF heart protection study JO - Circulation VL - 125 UR - https://doi.org/10.1161/CIRCULATIONAHA.111.073684 DO - 10.1161/CIRCULATIONAHA.111.073684 ID - Parish2012 ER - TY - JOUR AU - Baigent, C. AU - Keech, A. AU - Kearney, P. M. AU - Blackwell, L. AU - Buck, G. AU - Pollicino, C. AU - Kirby, A. AU - Sourjina, T. AU - Peto, R. AU - Collins, R. PY - 2005 DA - 2005// TI - Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins JO - Lancet VL - 366 UR - https://doi.org/10.1016/S0140-6736(05)67394-1 DO - 10.1016/S0140-6736(05)67394-1 ID - Baigent2005 ER - TY - JOUR AU - Miller, M. AU - Cannon, C. P. AU - Murphy, S. A. AU - Qin, J. AU - Ray, K. K. AU - Braunwald, E. AU - Investigators, P. I. -. T. PY - 2008 DA - 2008// TI - Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial JO - J Am Coll Cardiol VL - 51 UR - https://doi.org/10.1016/j.jacc.2007.10.038 DO - 10.1016/j.jacc.2007.10.038 ID - Miller2008 ER - TY - JOUR AU - Steen, D. L. AU - Umez-Eronini, A. A. AU - Guo, J. AU - Khan, N. AU - Cannon, C. P. PY - 2018 DA - 2018// TI - The effect of fasting status on lipids, lipoproteins, and inflammatory biomarkers assessed after hospitalization for an acute coronary syndrome: insights from PROVE IT-TIMI 22 JO - Clin Cardiol VL - 41 UR - https://doi.org/10.1002/clc.22851 DO - 10.1002/clc.22851 ID - Steen2018 ER - TY - JOUR AU - Wilson, S. R. AU - Sabatine, M. S. AU - Wiviott, S. D. AU - Ray, K. K. AU - Lemos, J. A. AU - Zhou, S. AU - Rifai, N. AU - Cannon, C. P. AU - Morrow, D. A. PY - 2011 DA - 2011// TI - Assessment of adiponectin and the risk of recurrent cardiovascular events in patients presenting with an acute coronary syndrome: observations from the pravastatin or atorVastatin evaluation and infection trial-thrombolysis in myocardial infarction 22 (PROVE IT-TIMI 22) JO - Am Heart J VL - 161 UR - https://doi.org/10.1016/j.ahj.2011.02.014 DO - 10.1016/j.ahj.2011.02.014 ID - Wilson2011 ER - TY - JOUR AU - Bohula, E. A. AU - Wiviott, S. D. AU - Giugliano, R. P. AU - Blazing, M. A. AU - Park, J. G. AU - Murphy, S. A. AU - White, J. A. AU - Mach, F. AU - Werf, F. AU - Dalby, A. J. PY - 2017 DA - 2017// TI - Prevention of stroke with the addition of ezetimibe to statin therapy in patients with acute coronary syndrome in IMPROVE-IT (Improved reduction of outcomes: Vytorin efficacy international trial) JO - Circulation VL - 136 UR - https://doi.org/10.1161/CIRCULATIONAHA.117.029095 DO - 10.1161/CIRCULATIONAHA.117.029095 ID - Bohula2017 ER - TY - JOUR AU - Jarcho, J. A. AU - Keaney, J. F. PY - 2015 DA - 2015// TI - Proof that lower is better--LDL cholesterol and IMPROVE-IT JO - N Engl J Med VL - 372 UR - https://doi.org/10.1056/NEJMe1507041 DO - 10.1056/NEJMe1507041 ID - Jarcho2015 ER - TY - STD TI - Kato ET, Cannon CP, Blazing MA, Bohula E, Guneri S, White JA, Murphy SA, Park JG, Braunwald E, Giugliano RP. Efficacy and safety of adding ezetimibe to statin therapy among women and men: insight from IMPROVE-IT (Improved reduction of outcomes: Vytorin efficacy international trial). J Am Heart Assoc. 2017;6. ID - ref48 ER - TY - STD TI - Nichols GA, Philip S, Reynolds K, Granowitz CB, Fazio S. Increased residual cardiovascular risk in patients with diabetes and high versus normal triglycerides despite statin-controlled LDL cholesterol. Diabetes Obes Metab. 2018. ID - ref49 ER - TY - JOUR AU - Cui, Y. AU - Blumenthal, R. S. AU - Flaws, J. A. AU - Whiteman, M. K. AU - Langenberg, P. AU - Bachorik, P. S. AU - Bush, T. L. PY - 2001 DA - 2001// TI - Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality JO - Arch Intern Med VL - 161 UR - https://doi.org/10.1001/archinte.161.11.1413 DO - 10.1001/archinte.161.11.1413 ID - Cui2001 ER - TY - JOUR AU - Pischon, T. AU - Girman, C. J. AU - Sacks, F. M. AU - Rifai, N. AU - Stampfer, M. J. AU - Rimm, E. B. PY - 2005 DA - 2005// TI - Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men JO - Circulation VL - 112 UR - https://doi.org/10.1161/CIRCULATIONAHA.104.532499 DO - 10.1161/CIRCULATIONAHA.104.532499 ID - Pischon2005 ER - TY - JOUR AU - Mora, S. a. m. i. a. AU - Ridker, P. a. u. l. M. PY - 2006 DA - 2006// TI - Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER)β€”Can C-Reactive Protein Be Used to Target Statin Therapy in Primary Prevention? JO - The American Journal of Cardiology VL - 97 UR - https://doi.org/10.1016/j.amjcard.2005.11.014 DO - 10.1016/j.amjcard.2005.11.014 ID - Mora2006 ER - TY - JOUR AU - Boekholdt, S. M. AU - Arsenault, B. J. AU - Mora, S. AU - Pedersen, T. R. AU - LaRosa, J. C. AU - Nestel, P. J. AU - Simes, R. J. AU - Durrington, P. AU - Hitman, G. A. AU - Welch, K. M. A. PY - 2012 DA - 2012// TI - Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins a meta-analysis JO - Jama-Journal of the American Medical Association VL - 307 UR - https://doi.org/10.1001/jama.2012.366 DO - 10.1001/jama.2012.366 ID - Boekholdt2012 ER - TY - JOUR AU - Sondermeijer, B. M. AU - Rana, J. S. AU - Arsenault, B. J. AU - Shah, P. K. AU - Kastelein, J. J. AU - Wareham, N. J. AU - Boekholdt, S. M. AU - Khaw, K. T. PY - 2013 DA - 2013// TI - Non-HDL cholesterol vs. apo B for risk of coronary heart disease in healthy individuals: the EPIC-Norfolk prospective population study JO - Eur J Clin Investig VL - 43 UR - https://doi.org/10.1111/eci.12129 DO - 10.1111/eci.12129 ID - Sondermeijer2013 ER - TY - JOUR AU - Wongcharoen, W. AU - Sutthiwutthichai, S. AU - Gunaparn, S. AU - Phrommintikul, A. PY - 2017 DA - 2017// TI - Is non-HDL-cholesterol a better predictor of long-term outcome in patients after acute myocardial infarction compared to LDL-cholesterol? : A retrospective study JO - BMC Cardiovasc Disord VL - 17 UR - https://doi.org/10.1186/s12872-016-0450-9 DO - 10.1186/s12872-016-0450-9 ID - Wongcharoen2017 ER - TY - JOUR AU - Oliveira Alvim, R. AU - Mourao-Junior, C. A. AU - Magalhaes, G. L. AU - Oliveira, C. M. AU - Krieger, J. E. AU - Mill, J. G. AU - Pereira, A. C. PY - 2017 DA - 2017// TI - Non-HDL cholesterol is a good predictor of the risk of increased arterial stiffness in postmenopausal women in an urban Brazilian population JO - Clinics (Sao Paulo) VL - 72 UR - https://doi.org/10.6061/clinics/2017(02)07 DO - 10.6061/clinics/2017(02)07 ID - Oliveira Alvim2017 ER - TY - JOUR AU - Rana, J. S. AU - Liu, J. Y. AU - Moffet, H. H. AU - Boklage, S. H. AU - Khan, I. AU - Karter, A. J. PY - 2018 DA - 2018// TI - Risk of incident atherosclerotic cardiovascular DiseaseEvents by achieved Atherogenic lipid levels Among62,428 statin-treated individuals with diabetes mellitus JO - Am J Cardiol VL - 122 UR - https://doi.org/10.1016/j.amjcard.2018.05.011 DO - 10.1016/j.amjcard.2018.05.011 ID - Rana2018 ER - TY - JOUR AU - Cao, Y. AU - Yan, L. AU - Guo, N. AU - Yu, N. AU - Wang, Y. AU - Cao, X. AU - Yang, S. AU - Lv, F. PY - 2018 DA - 2018// TI - Non-high-density lipoprotein cholesterol and risk of cardiovascular disease in the general population and patients with type 2 diabetes: a systematic review and meta-analysis JO - Diabetes Res Clin Pract VL - 147 UR - https://doi.org/10.1016/j.diabres.2018.11.002 DO - 10.1016/j.diabres.2018.11.002 ID - Cao2018 ER - TY - JOUR AU - Kastelein, J. J. AU - Steeg, W. A. AU - Holme, I. AU - Gaffney, M. AU - Cater, N. B. AU - Barter, P. AU - Deedwania, P. AU - Olsson, A. G. AU - Boekholdt, S. M. AU - Demicco, D. A. PY - 2008 DA - 2008// TI - Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment JO - Circulation VL - 117 UR - https://doi.org/10.1161/CIRCULATIONAHA.107.713438 DO - 10.1161/CIRCULATIONAHA.107.713438 ID - Kastelein2008 ER - TY - JOUR AU - Robinson, J. G. AU - Wang, S. AU - Smith, B. J. AU - Jacobson, T. A. PY - 2009 DA - 2009// TI - Meta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease risk JO - J Am Coll Cardiol VL - 53 UR - https://doi.org/10.1016/j.jacc.2008.10.024 DO - 10.1016/j.jacc.2008.10.024 ID - Robinson2009 ER - TY - JOUR AU - Lee, E. Y. AU - Yang, Y. AU - Kim, H. S. AU - Cho, J. H. AU - Yoon, K. H. AU - Chung, W. S. AU - Lee, S. H. AU - Chang, K. PY - 2018 DA - 2018// TI - Effect of visit-to-visit LDL-, HDL-, and non-HDL-cholesterol variability on mortality and cardiovascular outcomes after percutaneous coronary intervention JO - Atherosclerosis VL - 279 UR - https://doi.org/10.1016/j.atherosclerosis.2018.10.012 DO - 10.1016/j.atherosclerosis.2018.10.012 ID - Lee2018 ER - TY - JOUR AU - Khaloo, P. AU - Hasheminia, M. AU - Tohidi, M. AU - Abdi, H. AU - Mansournia, M. A. AU - Azizi, F. AU - Hadaegh, F. PY - 2018 DA - 2018// TI - Impact of 3-year changes in lipid parameters and their ratios on incident type 2 diabetes: Tehran lipid and glucose study JO - Nutr Metab (Lond) VL - 15 UR - https://doi.org/10.1186/s12986-018-0287-6 DO - 10.1186/s12986-018-0287-6 ID - Khaloo2018 ER - TY - JOUR AU - Blaha, M. J. AU - Blumenthal, R. S. AU - Brinton, E. A. AU - Jacobson, T. A. PY - 2008 DA - 2008// TI - Non-HDL NLAT: The importance of non-HDL cholesterol reporting in lipid management JO - Journal of Clinical Lipidology VL - 2 UR - https://doi.org/10.1016/j.jacl.2008.06.013 DO - 10.1016/j.jacl.2008.06.013 ID - Blaha2008 ER - TY - JOUR AU - Degoma, E. M. AU - Davis, M. D. AU - Dunbar, R. L. AU - Mohler, E. R. AU - Greenland, P. AU - French, B. PY - 2013 DA - 2013// TI - Discordance between non-HDL-cholesterol and LDL-particle measurements: results from the multi-ethnic study of atherosclerosis JO - Atherosclerosis VL - 229 UR - https://doi.org/10.1016/j.atherosclerosis.2013.03.012 DO - 10.1016/j.atherosclerosis.2013.03.012 ID - Degoma2013 ER - TY - JOUR AU - Elshazly, M. B. AU - Quispe, R. AU - Michos, E. D. AU - Sniderman, A. D. AU - Toth, P. P. AU - Banach, M. AU - Kulkarni, K. R. AU - Coresh, J. AU - Blumenthal, R. S. AU - Jones, S. R. AU - Martin, S. S. PY - 2015 DA - 2015// TI - Patient-level discordance in population percentiles of the Total cholesterol to high-density lipoprotein cholesterol ratio in comparison with low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol: the very large database of lipids study (VLDL-2B) JO - Circulation VL - 132 UR - https://doi.org/10.1161/CIRCULATIONAHA.115.016163 DO - 10.1161/CIRCULATIONAHA.115.016163 ID - Elshazly2015 ER - TY - JOUR AU - Anderson, T. J. AU - Gregoire, J. AU - Hegele, R. A. AU - Couture, P. AU - Mancini, G. B. AU - McPherson, R. AU - Francis, G. A. AU - Poirier, P. AU - Lau, D. C. AU - Grover, S. PY - 2013 DA - 2013// TI - 2012 update of the Canadian cardiovascular society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult JO - Can J Cardiol VL - 29 UR - https://doi.org/10.1016/j.cjca.2012.11.032 DO - 10.1016/j.cjca.2012.11.032 ID - Anderson2013 ER - TY - JOUR AU - Contois, J. H. AU - McConnell, J. P. AU - Sethi, A. A. AU - Csako, G. AU - Devaraj, S. AU - Hoefner, D. M. AU - Warnick, G. R. AU - Lipoproteins, A. PY - 2009 DA - 2009// TI - Vascular diseases division working group on Best P: apolipoprotein B and cardiovascular disease risk: position statement from the AACC Lipoproteins and vascular diseases division working group on Best practices JO - Clin Chem VL - 55 UR - https://doi.org/10.1373/clinchem.2008.118356 DO - 10.1373/clinchem.2008.118356 ID - Contois2009 ER - TY - JOUR AU - Genest, J. AU - McPherson, R. AU - Frohlich, J. AU - Anderson, T. AU - Campbell, N. AU - Carpentier, A. AU - Couture, P. AU - Dufour, R. AU - Fodor, G. AU - Francis, G. A. PY - 2009 DA - 2009// TI - 2009 Canadian cardiovascular society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations JO - Can J Cardiol VL - 25 UR - https://doi.org/10.1016/S0828-282X(09)70715-9 DO - 10.1016/S0828-282X(09)70715-9 ID - Genest2009 ER - TY - STD TI - Authors/Task Force M, Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, Hoes AW, Jennings CS, Landmesser U, et al. 2016 ESC/EAS guidelines for the Management of Dyslipidaemias: the task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European atherosclerosis society (EAS) developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR). Atherosclerosis. 2016(253):281–344. ID - ref69 ER - TY - JOUR AU - Quispe, R. AU - Manalac, R. J. AU - Faridi, K. F. AU - Blaha, M. J. AU - Toth, P. P. AU - Kulkarni, K. R. AU - Nasir, K. AU - Virani, S. S. AU - Banach, M. AU - Blumenthal, R. S. PY - 2015 DA - 2015// TI - Relationship of the triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio to the remainder of the lipid profile: the very large database of Lipids-4 (VLDL-4) study JO - Atherosclerosis VL - 242 UR - https://doi.org/10.1016/j.atherosclerosis.2015.06.057 DO - 10.1016/j.atherosclerosis.2015.06.057 ID - Quispe2015 ER - TY - JOUR AU - Al-Hashmi, K. AU - Al-Zakwani, I. AU - Mahmeed, W. AU - Arafah, M. AU - Al-Hinai, A. T. AU - Shehab, A. AU - Tamimi, O. AU - Awadhi, M. AU - Herz, S. AU - Anazi, F. PY - 2016 DA - 2016// TI - Non-high-density lipoprotein cholesterol target achievement in patients on lipid-lowering drugs and stratified by triglyceride levels in the Arabian gulf JO - J Clin Lipidol VL - 10 UR - https://doi.org/10.1016/j.jacl.2015.12.021 DO - 10.1016/j.jacl.2015.12.021 ID - Al-Hashmi2016 ER - TY - JOUR AU - Pongsuthana, S. AU - Tivatunsakul, N. PY - 2016 DA - 2016// TI - Optimal fasting time before measurement of serum triglyceride levels in healthy volunteers JO - J Med Assoc Thail VL - 99 ID - Pongsuthana2016 ER - TY - JOUR AU - Yue, F. AU - Zhang, G. AU - Tang, R. AU - Zhang, Z. AU - Teng, L. AU - Zhang, Z. PY - 2016 DA - 2016// TI - Age- and sex-related changes in fasting plasma glucose and lipoprotein in cynomolgus monkeys JO - Lipids Health Dis VL - 15 UR - https://doi.org/10.1186/s12944-016-0280-x DO - 10.1186/s12944-016-0280-x ID - Yue2016 ER - TY - JOUR AU - Ballantyne, C. M. AU - Pitt, B. AU - Loscalzo, J. AU - Cain, V. A. AU - Raichlen, J. S. PY - 2013 DA - 2013// TI - Alteration of relation of atherogenic lipoprotein cholesterol to apolipoprotein B by intensive statin therapy in patients with acute coronary syndrome (from the limiting UNdertreatment of lipids in ACS with Rosuvastatin [LUNAR] trial) JO - Am J Cardiol VL - 111 UR - https://doi.org/10.1016/j.amjcard.2012.10.037 DO - 10.1016/j.amjcard.2012.10.037 ID - Ballantyne2013 ER - TY - JOUR AU - Elshazly, M. B. AU - Martin, S. S. AU - Blaha, M. J. AU - Joshi, P. H. AU - Toth, P. P. AU - McEvoy, J. W. AU - Al-Hijji, M. A. AU - Kulkarni, K. R. AU - Kwiterovich, P. O. AU - Blumenthal, R. S. AU - Jones, S. R. PY - 2013 DA - 2013// TI - Non-high-density lipoprotein cholesterol, guideline targets, and population percentiles for secondary prevention in 1.3 million adults: the VLDL-2 study (very large database of lipids) JO - J Am Coll Cardiol VL - 62 UR - https://doi.org/10.1016/j.jacc.2013.07.045 DO - 10.1016/j.jacc.2013.07.045 ID - Elshazly2013 ER - TY - JOUR AU - Kuwabara, K. AU - Harada, S. AU - Sugiyama, D. AU - Kurihara, A. AU - Kubota, Y. AU - Higashiyama, A. AU - Hirata, T. AU - Nishida, Y. AU - Kawasaki, M. AU - Takebayashi, T. AU - Okamura, T. PY - 2016 DA - 2016// TI - Relationship between non-high-density lipoprotein cholesterol and low-density lipoprotein cholesterol in the general population JO - J Atheroscler Thromb VL - 23 UR - https://doi.org/10.5551/jat.33100 DO - 10.5551/jat.33100 ID - Kuwabara2016 ER - TY - JOUR AU - Brito, F. A. AU - Pedrosa, W. AU - Maluf, C. B. AU - Reis, R. C. P. AU - Fedeli, L. M. G. AU - Castilhos, C. AU - Barreto, S. M. AU - Vidigal, P. G. PY - 2018 DA - 2018// TI - Non-HDL-C goals based on the distribution of population percentiles in ELSA-Brasil: is it time to change? JO - Atherosclerosis VL - 274 UR - https://doi.org/10.1016/j.atherosclerosis.2018.04.007 DO - 10.1016/j.atherosclerosis.2018.04.007 ID - Brito2018 ER -